Identification of a domain within peroxisome proliferator-activated receptor γ regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes

Molecular and Cellular Biology

Volumn 28, Issue 1, 2008, Pages 188-200

  Wang, Hong ^a   Qiang, Li ^a   Farmer, Stephen R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINO ACID; FIBROBLAST GROWTH FACTOR 21; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIRTUIN 1; TROGLITAZONE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN DOMAIN; RNA INTERFERENCE;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CHROMANS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIGANDS; MICE; PPAR GAMMA; SIRTUINS; SWISS 3T3 CELLS; THIAZOLIDINEDIONES;

EID: 37549052177     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00992-07     Document Type: Article

References (37)

1. Badman, M. K., P. Pissios, A. R. Kennedy, G. Koukos, J. S. Flier, and E. Maratos-Flier. 2007. Hepatic fibroblast growth factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5:426-437.
2. Berger, J., M. Tanen, A. Elbrecht, A. Hermanowski-Vosatka, D. E. Moller, S. D. Wright, and R. Thieringer. 2001. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity. J. Biol. Chem. 276:12629-12635.
3. Castriota, G., G. M. Thompson, Y. Lin, P. E. Scherer, D. E. Moller, and J. P. Berger. 2006. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of α1-acid glycoprotein. Cell Biol. Int. 31:586-591.
4. Cheung, K. J., I. Tzameli, P. Pissios, I. Rovira, O. Gavrilova, T. Ohtsubo, Z. Chen, T. Finkel, J. S. Flier, and J. M. Friedman. 2007. Xanthine oxidoreductase is a regulator of adipogenesis and PPARγ activity. Cell Metab. 5:115-128.
5. Chui, P. C., H. P. Guan, M. Lehrke, and M. A. Lazar. 2005. PPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J. Clin. Investig. 115:2244-2256.
6. Evans, R. M., G. D. Barish, and Y. X. Wang. 2004. PPARs and the complex journey to obesity. Nat. Med. 10:355-361.
7. Fajas, L., M. B. Debril, and J. Auwerx. 2001. PPAR gamma: an essential role in metabolic control. Nutr. Metab. Cardiovasc. Dis. 11:64-69.
8. Farmer, S. R. 2006. Transcriptional control of adipocyte formation. Cell Metab. 4:263-273.
9. Fasshauer, M., J. Klein, K. M. Kriauciunas, K. Ueki, M. Benito, and C. R. Kahn. 2001. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol. Cell. Biol. 21:319-329.
10. Fasshauer, M., J. Klein, K. Ueki, K. M. Kriauciunas, M. Benito, M. F. White, and C. R. Kahn. 2000. Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J. Biol. Chem. 275:25494-25501.
11. Ge, K., M. Guennah, C. X. Yuan, M. Ito, A. E. Wallberg, B. M. Spiegelman, and R. G. Roeder. 2002. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 417:563-567.
12. Guan, H. P., T. Ishizuka, P. C. Chui, M. Lehrke, and M. A. Lazar. 2005. Corepressors selectively control the transcriptional activity of PPARγ in adipocytes. Genes Dev. 19:453-461.
13. Guan, H. P., Y. Li, M. V. Jensen, C. B. Newgard, C. M. Steppan, and M. A. Lazar. 2002. A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med. 8:1122-1128.
14. Hamm, J. K., B. H. Park, and S. R. Farmer. 2001. A role for C/EBPβ in regulating peroxisome proliferator-activated receptor gamma activity during adipogenesis in 3T3-L1 prcadipocytes. J. Biol. Chem. 276:18464-18471.
15. Inagaki, T., P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, V. Esser, J. K. Elmquist, R. D. Gerard, S. C. Burgess, R. E. Hammer, D. J. Mangelsdorf, and S. A. Kliewer. 2007. Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab. 5:415-425.
16. Kharitonenkov, A., T. L. Shiyanova, A. Koester, A. M. Ford, R. Micanovic, E. J. Galbreath, G. E. Sandusky, L. J. Hammond, J. S. Moyers, R. A. Owens, J. Gromada, J. T. Brozinick, E. D. Hawkins, V. J. Wroblewski, D. S. Li, F. Mehrbod, S. R. Jaskunas, and A. B. Shanafelt. 2005. FGF-21 as a novel metabolic regulator. J. Clin. Investig. 115:1627-1635.
17. Kim, J. B., H. M. Wright, M. Wright, and B. M. Spiegelman. 1998. ADD1/ SREBP1 activates PPAR gamma through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA 95:4333-4337.
18. Kliewer, S. A., H. E. Xu, M. H. Lambert, and T. M. Willson. 2001. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog. Horm. Res. 56:239-263.
19. Krey, G., O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M. G. Parker, and W. Wahli. 1997. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11:779-791.
20. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270:12953-12956.
21. Lehrke, M., and M. A. Lazar. 2005. The many faces of PPARγ. Cell 123: 993-999.
22. Liu, J., H. Wang, Y. Zuo, and S. R. Farmer. 2006. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol. Cell. Biol. 26:5827-5837.
23. Madsen, L., R. K. Petersen, M. B. Sorensen, C. Jorgensen, P. Hallenborg, L. Pridal, J. Fleckner, E.-Z. Amri, P. Krieg, G. Furstenberger, R. K. Berge, and K. Kristiansen. 2003. Adipocyte differentiation of 3T3-L1 preadipocytes is dependent on lipoxygenase activity during the initial stages of the differentiation process. Biochem. J. 375:539-549.
24. Nolte, R. T., G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, and M. V. Milburn. 1998. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395:137-143.
25. Ogawa, Y., H. Kurosu, M. Yamamoto, A. Nandi, K. P. Rosenblatt, R. Goetz, A. V. Eliseenkova, M. Mohammadi, and M. Kuro-o. 2007. βKlotho is required for metabolic activity of fibroblast growth factor 21. Proc. Natl. Acad. Sci. USA 104:7432-7437.
26. Pascual, G., A. L. Fong, S. Ogawa, A. Gamliel, A. C. Li, V. Perissi, D. W. Rose, T. M. Willson, M. G. Rosenfeld, and C. K. Glass. 2005. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature 437:759-763.
27. Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.
28. Picard, F., M. Kurtev, N. Chung, A. Topark-Ngarm, T. Senawong, R. Machado De Oliveira, M. Leid, M. W. McBurney, and L. Guarente. 2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429:771-776.
29. Qi, C., S. Surapureddi, Y. J. Zhu, S. Yu, P. Kashireddy, M. S. Rao, and J. K. Reddy. 2003. Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARγ)-interacting protein, is required for PPARγ-mediated adipogenesis. J. Biol. Chem. 278:25281-25284.
30. Qiang, L., H. Wang, and S. R. Farmer. 2007. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-Lα. Mol. Cell. Biol. 27:4698-4707.
31. Rodgers, J. T., C. Lerin, W. Haas, S. P. Gygi, B. M. Spiegelman, and P. Puigserver. 2005. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434:113-118.
32. Rosen, E. D., and B. M. Spiegelman. 2001. PPARγ: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276:37731-37734.
33. Schadinger, S. E., N. L. Bucher, B. M. Schreiber, and S. R. Farmer. 2005. PPARγ2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288:E1195- E1205.
34. Steppan, C. M., and M. A. Lazar. 2002. Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 13:18-23.
35. Tzameli, I., H. Fang, M. Ollero, H. Shi, J. K. Hamm, P. Kievit, A. N. Hollenberg, and J. S. Flier. 2004. Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J. Biol. Chem. 279:36093-36102.
36. Wang, Z. V., T. D. Schraw, J. Y. Kim, T. Khan, M. W. Rajala, A. Follenzi, and P. E. Scherer. 2007. Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Mol. Cell. Biol. 27:3716-3731.
37. Willson, T. M., M. H. Lambert, and S. A. Kliewer. 2001. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu. Rev. Biochem. 70:341-367.